Categories AlphaGraphs, Earnings, Technology

AVGO Earnings: Broadcom reports higher Q4 FY25 revenue, profit; results beat

Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) on Thursday reported an increase in revenue and adjusted earnings for the fourth quarter of fiscal 2025. The numbers also surpassed analysts’ expectations.

Broadcom Q4 2025 Earnings

Adjusted earnings rose sharply to $1.95 per share in the fourth quarter from $1.42 per share in the prior-year period, beating estimates. On an unadjusted basis, net income was $8.52 billion or $1.74 per share in Q4, vs. $4.32 billion or $0.90 per share in the fourth quarter of 2024.

Fourth-quarter revenues were $18.0 billion, compared to $14.1 billion in the corresponding quarter a year earlier. Revenues came in above analysts’ forecasts.

Broadcom’s CEO Hock Tan said, ” In Q4, record revenue of $18.0 billion grew 28% year-over-year, driven primarily by AI semiconductor revenue increasing 74% year-over-year. We see the momentum continuing in Q1 and expect AI semiconductor revenue to double year-over-year to $8.2 billion, driven by custom AI accelerators and Ethernet AI switches.”

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

After a rollercoaster year, is Tesla (TSLA) stock a good bet?

In recent years, Tesla's (NASDAQ: TSLA) stock has often swung between record highs and sharp corrections, reflecting shifts in investor sentiment, broader economic conditions, and changes in its financial performance.

Dollar Tree (DLTR), Dollar General (DG): Discount stores remain key gainers in a value-conscious landscape

Discount retailers Dollar Tree, Inc. (NASDAQ: DLTR) and Dollar General Corporation (NYSE: DG) have seen their stocks gain more than 30% in the past three months. The dollar stores continue

Everything you need to know about Aktis Oncology’s upcoming IPO

IPO activity in 2025 showed a marked rebound, led by the technology and healthcare sectors, after last year's sluggish performance. Aktis Oncology, which develops radiopharmaceuticals for solid tumors, is the

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top